Viridian announces topline data from THRIVE-2 phase 3 clinical trial of veligrotug for treatment of thyroid eye disease
THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.
THRIVE-2 met all primary and secondary endpoints at the 15-week primary analysis timepoint after 5 infusions of veligrotug.
Research data published earlier this year could help clinicians gain a better understanding of what to look for in a specular microscope, and how to…
The Ophthalmology Journal podcast reviews research articles, editorials, and more from the Academy’s journal family: Ophthalmology, Ophthalmology Retina, Ophthalmology Glaucoma
The diagnosis of fungal keratitis using potassium hydroxide (KOH) smears of corneal scrapings enables initiation of the correct antimicrobial therapy at the point-of-care but requires…
Wills Eye Resident Series : A patient presents with decreased vision after an injury , p. 62 medicare Q & A 2024 Reimbursement Update Wills…
A global survey explores the impact of geographic atrophy (GA) on quality of life, revealing similar challenges for individuals with unilateral and bilateral GA. Researchers…
Nature Communications – Osada et al. used MRI and brain stimulation to outline the macroscopic cerebral circuits for response inhibition: visual cortex→dorsal anterior insula→inferior…
(NAPSI)—Many people don’t know it but diabetes is a leading cause of vision loss. Fortunately, early detection could save your vision. Unfortunately, most people with…
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
To quantify relevant fundus autofluorescence (FAF) image features cross-sectionally and longitudinally in a large cohort of patients with inherited retinal diseases (IRDs).
➤ Positive topline data in Phase 1/2 allogenic cell therapy trial ➤ Investigational, light-based treatment for infectious keratitis ➤ Topline results from Phase 3 clinical…